Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Employees

4,619

Sector

Pharmaceuticals

Calendar

Aug. 14 - Q2 2025 Earnings Release

More about the company

Quotes

Date	Price	Change	Volume
25-07-14	34.97 ¥	+5.65%	15,752,260
25-07-14	33.10 ¥	-0.24%	3,127,501
25-07-11	33.18 ¥	+0.73%	3,857,516
25-07-10	32.94 ¥	+0.92%	4,197,400
25-07-09	32.64 ¥	+0.25%	3,466,194

End-of-day quote Shanghai S.E., July 14, 2025

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

34.97

Average target price

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

End-of-day quote Shanghai S.E. Other stock markets 2025-07-15			5-day change	1st Jan Change
34.97 ^CNY	+5.65%		+7.67%	+13.54%

Jul. 14	Tianjin Pharmaceutical Da Ren Tang Group Estimates Increased Attributable Profit in H1	MT
Jul. 14	Tianjin Pharmaceutical Da Ren Tang sees H1 net profit up 180-204% Y/Y	RE

Capitalization	23.51B 3.28B 2.82B 2.63B 2.45B 4.5B 282B 5.03B 31.82B 12.03B 132B 12.29B 12.04B 488B	P/E ratio 2025 *	32.4x	P/E ratio 2026 *	28.9x
Enterprise value	23.51B 3.28B 2.82B 2.63B 2.45B 4.5B 282B 5.03B 31.82B 12.03B 132B 12.29B 12.04B 488B	EV / Sales 2025 *	4.79x	EV / Sales 2026 *	4.4x
Free-Float	31.72%	Yield 2025 *	-	Yield 2026 *	-

Tianjin Pharmaceutical Da Ren Tang Group Estimates Increased Attributable Profit in H1	Jul. 14	MT
Tianjin Pharmaceutical Da Ren Tang sees H1 net profit up 180-204% Y/Y	Jul. 14	RE
Tianjin Pharmaceutical Da Ren Tang Completes Disposal of 12% Stake in Tianjin TSKF; Shares Up 2%	Jun. 30	MT
Haleon plc completed the acquisition of remaining 12% stake in Tianjin TSKF Pharmaceutical Co. Ltd from Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited.	Jun. 26	CI
Tianjin Pharmaceutical Da Ren Tang Signs Lease Agreement	Jun. 23	MT
Tianjin Pharmaceutical Da Ren Tang Attributable Profit Shrinks in Q1	Apr. 29	MT
Tianjin Pharma's Attributable Profit Slips 3% in Q1	Apr. 29	MT
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2025	Apr. 29	CI
Singapore Equities Extend Gains Despite US Curbs on China-Bound Nvidia Chips	Apr. 16	MT
Tianjin Pharma to Dispose of Remaining 12% Stake in Tianjin TSKF Pharmaceutical	Apr. 15	MT
Haleon China Co., Ltd., and Haleon CH SARL agreed to acquire 12% stake in Sino-American Tianjin Smith Kline & French Laboratories Ltd. from Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited for CNY 1.6 billion.	Apr. 15	CI
Deals of the day-Mergers and acquisitions	Apr. 15	RE
UK's Haleon takes full control of Chinese consumer healthcare venture	Apr. 15	RE

Nouveau feu d'artifice boursier en Chine	24-09-30
En direct des marchés : Stellantis avertit, Volkswagen avertit, Aston Martin avertit	24-09-30
Borsa di Italia: nuovi fuochi d'artificio sul mercato azionario cinese	24-09-30
Bolsa de Madrid: Nuevos fuegos artificiales bursátiles en China	24-09-30

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock

Equities

600329

CNE000001808

Pharmaceuticals

Valuation: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Chart: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Latest news: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Press Releases: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

News in other languages: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Quotes and Performance

Course Extremes

Managers and Directors: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Alternative Medicine

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Annual profits - Rate of surprise

1 day	+5.65%
1 week	+7.67%
Current month	+4.83%
1 month	+3.40%
3 months	+15.18%
6 months	+15.83%
Current year	+13.54%

1 week	32.4	35.53
1 month	31.68	35.53
Current year	28.53	35.53
1 year	26.16	39.05
3 years	21.05	56.26
5 years	15.8	56.26
10 years	11.8	56.26

Manager	Title	Age	Since
Jian Ma DFI	Director of Finance/CFO	47	2023-07-20
Hong Zhou CTO	Chief Tech/Sci/R&D Officer	55	2017-10-09
Jian Wang IRC	Investor Relations Contact	-	-

Director	Title	Age	Since
Lei Wang CHM	Chairman	54	2024-11-25
Hong Zhou BRD	Director/Board Member	55	2012-11-30
Yoke Pheng Liew BRD	Director/Board Member	69	2020-06-04

	2025 *	2026 *
Net sales	4.91B 684M 589M 548M 511M 939M 58.84B 1.05B 6.64B 2.51B 27.52B 2.57B 2.51B 102B	5.35B 746M 642M 597M 557M 1.02B 64.11B 1.14B 7.24B 2.74B 29.99B 2.8B 2.74B 111B
Net income	830M 116M 99.65M 92.72M 86.39M 159M 9.95B 178M 1.12B 425M 4.65B 434M 425M 17.23B	933M 130M 112M 104M 97.11M 178M 11.18B 200M 1.26B 478M 5.23B 488M 478M 19.37B
Net Debt	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.65%	+7.67%	+8.57%	+45.83%	3.12B
DONG-E-E-JIAO CO.,LTD.	-1.35%	-4.37%	-11.94%	+31.26%	4.46B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-1.14%	+1.37%	-5.31%	-42.81%	3.49B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	+0.08%	+1.90%	-17.26%	+6.99%	3.38B
TASLY PHARMACEUTICAL GROUP CO., LTD	-1.83%	-2.20%	+20.70%	+49.86%	3.31B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+3.25%	+7.42%	+14.76%	-8.44%	2.54B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	-0.91%	-1.54%	+23.32%	+86.40%	1.8B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	-0.79%	-3.44%	-4.74%	+88.15%	1.8B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-1.76%	-0.51%	+23.73%	-43.33%	1.67B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.53%	-1.06%	+16.03%	-12.65%	1.66B
Average	+0.07%	+0.44%	+6.79%	+20.13%	2.72B
Weighted average by Cap.	+0.12%	+0.44%	+3.76%	+19.14%